Molbio Diagnostics Ltd share price logo

Molbio Diagnostics Ltd

NSE: MOLBIO

BSE: 544866

Small Cap

₹1526.40

+28.80

(+1.92%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Molbio Diagnosti shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-31%

Searches for Molbio Diagnosti on INDmoney have decreased by 31% over the last 30 days.

Investment activity on INDmoney

-60.58%

Investment activity in Molbio Diagnosti among INDmoney users has decreased by 60.58% over the last 30 days.

Among the most traded stocks

301st

Molbio Diagnosti was the 301st most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

6 days

INDmoney investors hold Molbio Diagnosti shares for an average of 6 days.

Molbio Diagnosti Stock Performance

as on November 19, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,477.00
    ₹1,540.20
    downward going graph

    3.24%

    Downside

    0.90%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹926.35
    ₹1,686.80
    downward going graph

    39.31%

    Downside

    10.51%

    Upside

    downward going graph

Molbio Diagnosti share price movements today

Previous Close
₹1,497.60
Open
₹1,505.00
Volume
4.63L
Upper Circuit
₹1,797.10
Lower Circuit
₹1,198.10
Day's Low - High
₹1,477.00 - ₹1,540.20
52 Week Low - High
₹926.35 - ₹1,686.80

Molbio Diagnosti Historical Returns

1 Month Return
+ 4.38 %
3 Month Return
+ 44.47 %
1 Year Return
+ 43.76 %
3 Year Return
+ 43.76 %
5 Year Return
+ 43.76 %

Molbio Diagnosti Fundamentals

as on November 19, 2026 at 4:01 pm IST

Market Cap

₹17,258.34 Cr

Return on Equity (ROE)

13.61

PE Ratio (TTM)

102.65

Return on capital employed (ROCE)

17.63

Industry PE ratio

97.34

Beta (LTM)

0.3

P/B Ratio

0

Dividend Yield

0

PEG Ratio

14.77

Quarterly Earnings Growth YOY

-92.79

EPS (TTM)

0

Book Value

0

Molbio Diagnosti Stock Valuation

as on November 19, 2026 at 4:01 pm IST

Molbio Diagnosti in the last 5 years

  • Overview

  • Trends

Lowest (45.07x)

August 20, 2026

Industry (97.34x)

November 18, 2026

Today (102.65x)

November 18, 2026

Highest (107.91x)

October 16, 2026

LowHigh

Today’s Price to Earnings Ratio: 102.65x

Molbio Diagnosti Technical Analysis

Track how Molbio Diagnosti technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish12
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
1.83
Bullish
CCI (20)
-214.85
Bullish
RSI (14)
64.25
Neutral
Momentum (10)
4.5
Bearish
ADI (14)
23.59
Neutral
Ultimate Oscillator (7,14,28)
79.9
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1523.71
Bullish
EMA (20)
1524.9
Bullish
VWMA (20)
1525.37
Bullish
SMA (50)
1521.97
Bullish
EMA (50)
1522.5
Bullish
SMA (200)
1511.29
Bullish
EMA (200)
1513.8
Bullish
KAMA (200)
1519.81
Bullish
DEMA (200)
1523.15
Bullish

Molbio Diagnostics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Molbio Diagnosti with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA17,258.348.75%0.671641,445
NA27.5551.12%0.00135
BUY15,795.7333.32%0.66172814
NA14.86-2.69%0.00-1NA
NA35.3522.97%0.00116

Molbio Diagnostics Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
99.71
580.27
205.09
560.62
408.38
259.02
Other Income
0.76
1.09
2.84
4.79
3.1
5.77
Total Income
100.47
581.36
207.93
565.41
411.48
264.79
Expenses
115.81
412.83
196.39
401.9
307.79
215.07
Operating Profit
-16.1
167.44
8.7
158.72
100.59
43.95
Operating Profit Margin %
-16.15%
28.86%
4.24%
28.31%
24.63%
16.97%
Profit Before Interest, Tax and Depreciation
-15.35
168.53
11.55
163.51
103.68
49.72
Interest
3.61
6.98
10.8
12.08
10.7
8.86
Depreciation
12.32
13.81
17.91
19.6
17.08
23.36
Profit Before Tax
-31.28
147.74
-17.16
131.83
75.9
17.5
Tax Paid
-7.33
40.89
-2.57
36.01
23.17
9.8
Profit After Tax
-23.94
106.84
-14.59
95.83
52.74
7.7
Total Net profit including share of profit / Loss from associate company
-23.94
106.84
-14.59
95.83
52.74
7.7
EPS
-2.1
9.74
-
8.05
5.21
1.33
Actual EPS
-2.1
9.74
-
8.05
5.21
1.33
Adjusted EPS
-2.1
9.74
-
8.05
5.21
1.33
Diluted EPS
-2.1
9.74
-
8.05
5.21
1.33

Molbio Diagnostics Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
332.46
836.56
1,020.42
1,445.69
Other Income
4.95
4.1
7.52
9.48
Total Income
337.41
840.66
1,027.94
1,455.17
Expenses
289.3
655.57
771.3
1,126.93
Operating Profit
43.16
180.99
249.12
318.76
Operating Profit Margin %
12.98%
21.64%
24.41%
22.05%
Profit Before Interest, Tax and Depreciation
48.11
185.09
256.64
328.24
Interest
31.72
41.01
17.66
33.47
Depreciation
6.85
14.45
44.55
63.64
Profit Before Tax
9.54
129.63
194.43
231.13
Tax Paid
12.98
46.1
55.85
66.99
Profit After Tax
-3.45
83.54
138.58
164.14
Total Net profit including share of profit / Loss from associate company
-3.45
83.54
138.58
164.14
EPS
-0.06
9.05
64.06
14.77
Actual EPS
-0.06
9.05
64.06
14.77
Adjusted EPS
-0
0.18
12.81
14.77
Diluted EPS
-0.06
9.04
64.06
14.77

Molbio Diagnostics Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
-87.08
360.12
100.78
64.13
9.57
287.1
50.39
Cash Flow from Investing Activities
-17.32
-144.83
-88.14
-39.73
-45.01
-122.64
-53.91
Cash Flow from Financing Activities
109.89
-203.86
-21.94
18.24
-31.55
-26.15
276.07
Net Cash Flow
5.49
11.44
-9.31
42.64
-66.99
138.3
272.54

Molbio Diagnosti Stock Shareholding Pattern

Numbers in percentages

Aug 2025
Aug 2026
Sep 2026
Promoters
46.65%
41.29%
41.29%
DII
0%
16.37%
19.09%
FII
0%
1.51%
1.59%
Public
0%
40.82%
38.03%
Total Outstanding Shares
11,27,59,750
11,52,39,996
11,52,39,996
Total Shareholders
39
2,33,544
50,395

Mutual Funds Buying / Exiting Molbio Diagnosti

Holdings as of 15 Nov 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Molbio Diagnosti

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Kotak Focused Fund Direct Growth

Kotak Focused Fund Direct Growth

₹118.30 Cr

₹93.59 Cr (+378.75%)

2.33%

Mutual Funds Exiting Molbio Diagnosti

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Molbio Diagnosti Corporate Actions

View detailed summary of the earnings and dividend history of Molbio Diagnosti.

  • Molbio Diagnostics Ltd Earnings Results

    Molbio Diagnostics Ltd’s net profit fell -86.23% since last year same period to ₹15.12Cr in the Q2 2026-2027. On a quarterly growth basis, Molbio Diagnostics Ltd has generated -74.26% fall in its net profits since last 3-months.

    Read More

Indices Featuring Molbio Diagnosti Stock

Check stock indices that include Molbio Diagnosti.

BSE IPO

₹19,666.12

+240.80 (▲1.24%)

Insights on Molbio Diagnostics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.25% to 8.03% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.51% to 1.59% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MOLBIO stock has moved up by 7.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 41.29% of holdings in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 40.82% to 38.03% in Sep 2026 quarter

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited at Panaji as a private company dated October 20 2000. Thereafter Company was converted from a private limited company to a public limited company and the name of Company was changed to Molbio Diagnostics Limited and a fresh certificate of incorporation dated January 16 2025 was issued to Company by the RoC.Company is innovative pointofcare POC diagnostics company focused on expanding access to accurate rapid and costeffective healthcare technologies to diagnose infectious and noncommunicable diseases. The Company entered into a joint venture agreement in August 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited which started operations in 2000. Bigtec Innovations Private Limited got merged with the Company in 2015. It has developed Truenat platform in 2015 which is a novel POC polymerase chain reaction PCR platform that can operate in resource limited settings since its battery operated facilitating decentralized diagnosis within an hour.The Company works five manufacturing facilities in India of which two are in Goa one in Bengaluru Karnataka and one in Visakhapatnam Andhra Pradesh. Company is mainly engaged in the business of manufacturing chip based diagnostic devices chips and reagents Xray equipments single / dual detector solutions developing diagnostic devices performing tests in the biosensing domain digital pathology etc.In addition to this it offer products globally to public health programs diagnostic laboratories and private and public hospitals.In February 2023 Company acquired 65.47 of the equity share capital of Prognosys Medical Systems Pvt Ltd to venture into radiology equipment. Further in October 2024 Company acquired a 19.68 equity stake in OptraScan Inc. a USA based company to diversify to digital pathology scanners. Company is planning to raise Rs 200 Cr fresh issue equity shares by way of initial public offer and by issuing 12556000 equity shares of Re 1 each through offer for sale..

Revenue: ₹259.02Cr as on September 2026 (Q2 FY27)
Net Profit: ₹7.70Cr as on September 2026 (Q2 FY27)
Listing date: 17 Aug, 2026
OrganisationMolbio Diagnostics Ltd
HeadquartersGoa
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs

What is Molbio Diagnosti share price today?

Molbio Diagnosti share price today stands at ₹1526.4 as on at the close of the market. Molbio Diagnosti share today touched a day high of ₹1540.2 and a low of ₹1477.

What is the 52 week high and 52 week low range for Molbio Diagnosti share?

Molbio Diagnosti touched a 52 week high of ₹1686.8 and a 52 week low of ₹926.35. Molbio Diagnosti share price today i.e. is closed at ₹1526.4, which is -9.51% down from its 52 week high and 64.78% up from its 52 week low.

What is Molbio Diagnosti's market capitalisation today?

Molbio Diagnosti market capitalisation is ₹17,258.34 Cr as on .

How to buy Molbio Diagnosti shares?

To buy Molbio Diagnosti shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MOLBIO or Molbio Diagnostics Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Molbio Diagnosti shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Molbio Diagnosti trading volume today?

Molbio Diagnosti trading volume is 4.63L as on . This means that 4.63L shares of Molbio Diagnosti were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Molbio Diagnosti shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Molbio Diagnosti have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 6 days. This reflects platform activity only and is not investment advice.